Moscow, Russia

Olga Zolotareva

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bostongene Corporation. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olga Zolotareva. Retrieved from https://idiyas.com/inventor/olga-zolotareva

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Olga Zolotareva: Innovator in Cancer Vaccine Development

Introduction

Olga Zolotareva is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of cancer treatment through her innovative work on therapeutic vaccines. Her research focuses on developing methods that can potentially improve the lives of cancer patients.

Latest Patents

Olga Zolotareva holds a patent for "Construction and methods of use of a therapeutic cancer vaccine library comprising fusion-specific vaccines." This patent describes methods for constructing therapeutic fusion-specific vaccine libraries, selecting vaccines for cancer patients, and creating new vaccines for patients with specific gene fusions that are not included in existing libraries.

Career Highlights

Zolotareva is associated with Bostongene Corporation, where she applies her expertise in cancer research. Her work is pivotal in advancing the understanding and treatment of cancer through innovative vaccine development.

Collaborations

Olga collaborates with notable colleagues, including Maksym Artomov and Feliks Frenkel, who contribute to her research efforts and the advancement of therapeutic vaccine technologies.

Conclusion

Olga Zolotareva's contributions to cancer vaccine development highlight her role as an influential inventor in the medical field. Her innovative approaches have the potential to change the landscape of cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…